Effects of the Goal-directed Fluid Therapy on ASA 1 Patients Scheduled for Intensive Debulking Surgery
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Enrollment
- 60
- Primary Endpoint
- prevalence of complications
Study Overview
Brief Summary
In this retrospective analysis investigators will study the effects of using a minimally invasive hemodynamic monitoring (FloTrac-Edwards) on postoperative outcomes. Participants will compare a control group to a case group; in both groups ASA 1 patients suffering from advanced ovarian cancer underwent radical cytoreductive surgery. In case group hemodynamic was managed by using the FloTrac system; in the control group a standard hemodynamic monitoring was used.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Treatment
- Masking
- None
Eligibility Criteria
- Ages
- 18 Years to 65 Years (Adult, Older Adult)
- Sex
- Female
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- Not provided
Exclusion Criteria
- •cardiac diseases
- •pulmonary diseases
- •renal diseases
- •metabolic disorders
Arms & Interventions
control group
patients in which standard fluid administration was applied
case group
patients in which fluids were administered according to FloTrac parameters
Intervention: FloTrac (Device)
Outcomes
Primary Outcomes
prevalence of complications
Time Frame: up to 30 days
Secondary Outcomes
- days of hospitalization(up to 12 weeks)
Investigators
Dr.Andrea Russo
Medical Doctor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS